Joshua McGee

Chief Scientific Officer & Co-Founder · Keylicon Biosciences · company speakers →

Dr. Joshua McGee is the Chief Scientific Officer and Co-Founder of Keylicon Biosciences, where he leads development of next-generation vaccines and therapeutics across diverse targets. He earned his PhD in Biomedical Engineering from Boston University, where he developed modified self-amplifying RNA platforms, engineering lipid nanoparticle formulations, and designed novel saRNA vaccines and therapeutics.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

mRNA-Based Therapeutics Summit

20 July 2026 Boston, United States “Overcoming the Innate Immune Response of Self-Amplifying RNAs to Unlock Improved Vaccines & Therapeutics”

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →